Another study revealed serum total PSA concentrations to be significantly lower in women with breast cancer than women with benign breast disease and no significant difference was found between cancer patients and normal women; free PSA levels showed no difference in the groups (Borchert et al, 1997). Here, KLK3 is linked to breast fibrocystic disease.